168 related articles for article (PubMed ID: 33168019)
21. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
[No Abstract] [Full Text] [Related]
22. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.
Ruiz-Algueró M; Hernando V; Marcos H; Gutiérrez G; Pérez-Elías MJ; López-Bernaldo de Quirós JC; Pulido F; Górgolas M; Sanz J; Suarez-García I; Fernandez MT; Losa JE; Pérez JL; Ladrero MO; Prieto MÁ; González G; Izquierdo A; Viloria LJ; López I; Martínez E; Castrillejo D; Aranguren R; Belmonte MA; Aranda-García IV; Arraiza A; Diaz A;
BMC Infect Dis; 2021 Jan; 21(1):129. PubMed ID: 33516173
[TBL] [Abstract][Full Text] [Related]
23. Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria.
Peay HL; Rennie S; Cadigan RJ; Gwaltney A; Jupimai T; Phanuphak N; Kroon E; Colby DJ; Ormsby N; Isaacson SC; Vasan S; Sacdalan C; Prueksakaew P; Benjapornpong K; Ananworanich J; Henderson GE
AIDS Behav; 2022 May; 26(5):1504-1516. PubMed ID: 34997386
[TBL] [Abstract][Full Text] [Related]
24. Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.
Dubé K; Eskaf S; Hastie E; Agarwal H; Henley L; Roebuck C; Carter WB; Dee L; Taylor J; Mapp D; Campbell DM; Villa TJ; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207719
[TBL] [Abstract][Full Text] [Related]
25. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
26. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
[TBL] [Abstract][Full Text] [Related]
27. Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP
J Infect Dis; 2022 Aug; 226(2):236-245. PubMed ID: 35104873
[TBL] [Abstract][Full Text] [Related]
28. Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study.
Leyva-Moral JM; Loayza-Enriquez BK; Palmieri PA; Guevara-Vasquez GM; Elias-Bravo UE; Edwards JE; Feijoo-Cid M; Davila-Olano LY; Rodriguez-Llanos JR; Leon-Jimenez FE
AIDS Res Ther; 2019 Aug; 16(1):22. PubMed ID: 31462291
[TBL] [Abstract][Full Text] [Related]
29. Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa.
Barry A; Ford N; El-Khatib Z
Trop Med Int Health; 2018 Mar; 23(3):270-278. PubMed ID: 29243867
[TBL] [Abstract][Full Text] [Related]
30. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
Gonah L; Moodley I; Hlongwana K
Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
Julg B; Dee L; Ananworanich J; Barouch DH; Bar K; Caskey M; Colby DJ; Dawson L; Dong KL; Dubé K; Eron J; Frater J; Gandhi RT; Geleziunas R; Goulder P; Hanna GJ; Jefferys R; Johnston R; Kuritzkes D; Li JZ; Likhitwonnawut U; van Lunzen J; Martinez-Picado J; Miller V; Montaner LJ; Nixon DF; Palm D; Pantaleo G; Peay H; Persaud D; Salzwedel J; Salzwedel K; Schacker T; Sheikh V; Søgaard OS; Spudich S; Stephenson K; Sugarman J; Taylor J; Tebas P; Tiemessen CT; Tressler R; Weiss CD; Zheng L; Robb ML; Michael NL; Mellors JW; Deeks SG; Walker BD
Lancet HIV; 2019 Apr; 6(4):e259-e268. PubMed ID: 30885693
[TBL] [Abstract][Full Text] [Related]
33. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption.
Peluso MJ; Dee L; Campbell D; Taylor J; Hoh R; Rutishauser RL; Sauceda J; Deeks SG; Dubé K
J Virus Erad; 2020 Feb; 6(1):34-37. PubMed ID: 32175090
[TBL] [Abstract][Full Text] [Related]
34. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
[TBL] [Abstract][Full Text] [Related]
35. Exploring Treatment Needs and Expectations for People Living with HIV in South Africa: A Qualitative Study.
Earnshaw VA; Bogart LM; Courtney I; Zanoni H; Bangsberg DR; Orrell C; Goggin K; Katz IT
AIDS Behav; 2018 Aug; 22(8):2543-2552. PubMed ID: 29619585
[TBL] [Abstract][Full Text] [Related]
36. Analytical Treatment Interruptions and Human Immunodeficiency Virus Cure Research: Seizing the Opportunity While Maintaining Safety and Respect.
Hardy WD
Clin Infect Dis; 2020 Mar; 70(7):1418-1420. PubMed ID: 31102443
[No Abstract] [Full Text] [Related]
37. Time to Engage Young People in HIV Cure Research.
Saberi P; Campbell CK; Venegas M; Dubé K
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):2-4. PubMed ID: 33677996
[TBL] [Abstract][Full Text] [Related]
38. "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States.
Dubé K; Kanazawa J; Roebuck C; Johnson S; Carter WB; Dee L; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Dec; 23(1):120-135. PubMed ID: 35348047
[TBL] [Abstract][Full Text] [Related]
39. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.
Sneller MC; Huiting ED; Clarridge KE; Seamon C; Blazkova J; Justement JS; Shi V; Whitehead EJ; Schneck RF; Proschan M; Moir S; Fauci AS; Chun TW
J Infect Dis; 2020 Oct; 222(10):1655-1659. PubMed ID: 32443148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
